How can a design space beverified at commercial scale for biological products? - 分享质量人的知识和经验

登录

1: 关注

1033: 浏览

How can a design space beverified at commercial scale for biological products?

EMA

How can a design space beverified at commercial scale for biological products?

如何在生物产品的商业规模上验证设计空间？

好问题 0 评论收藏举报

查看全部 1 个回答

kk444555 一阶会员用户来自于: 广东省深圳市
2023-10-17 23:00

Principles laid down for chemical productsare applicable to biological products. In addition, verification studies shouldprovide evidence that the quality attributes of the product are comparableprior to and after the change. This could include a proposal for modular setsof tests and acceptance criteria to be deployed, taking into account the natureof the change and its associated risk.

为化学产品制定的原则适用于生物产品。此外，验证研究应提供证据证明产品的质量属性在变更前后具有可比性。这可能包括对采用的模块化检测和验收标准的提议，同时考虑到变更的性质及其相关风险。

赞同 0 0评论

关于作者

: 风清飞扬 二阶会员
这家伙很懒，还没有设置简介

149: 回答

84: 文章

475: 问题

问题动态

发布时间: 2023-10-17 23:00

更新时间: 2023-10-17 23:00

关注人数: 1 人关注

相关问题

What if unexpectedresults/events are obtained during the design space verification studies?: 1029 浏览 1 关注 1 回答 0 评论

How are sub-batches obtained and labelled?: 1034 浏览 1 关注 1 回答 0 评论

how to provide the CT related overview material andresearch data?: 1041 浏览 1 关注 1 回答 0 评论

How to select EMC test samples?: 934 浏览 1 关注 1 回答 0 评论

How should design spaceverification approach be addressed in the pharmaceutical quality system?: 1028 浏览 1 关注 1 回答 0 评论

How does FDA use the term “backup” in § 211.68(b)?: 901 浏览 1 关注 1 回答 0 评论

How is the unit quantity in a container calculated?: 993 浏览 1 关注 1 回答 0 评论

What is the difference betweenprocess validation and design space verification?: 1014 浏览 1 关注 1 回答 0 评论

How does FDA use the terms “static” and “dynamic” as they relate to record formats?: 943 浏览 1 关注 1 回答 0 评论

How should design spaceverification protocol be addressed in the submission?: 921 浏览 1 关注 1 回答 0 评论

推荐内容

问在同一设施中生产不同物种的兽药时要考虑什么？: 1008 浏览 1 关注 1 回答 0 评论

问生产过程中使用的设备变更，公司质量保证体系 (GMP) 涵盖哪些变更？: 897 浏览 1 关注 1 回答 0 评论

问如果原料药生产的发酵工艺中使用了蛋白胨（例如动物和植物来源），是否需要放在相关注册资料中？: 937 浏览 1 关注 1 回答 0 评论

问简单地在专用区内生产同一类治疗用途的药品进行分隔作为交叉污染风险控制方式是否可接受？: 1034 浏览 1 关注 1 回答 0 评论

问基于问卷调查、文件评审、ISO 9000认证、分析测试结果和与供应商的历史经验进行远程评估是否可以接受?: 973 浏览 1 关注 1 回答 0 评论

问 Why would a design space beverified during the product lifecycle?: 1059 浏览 1 关注 1 回答 0 评论

问 How should design spaceverification approach be addressed in the pharmaceutical quality system?: 1028 浏览 1 关注 1 回答 0 评论

问 EMA是什么机构: 6520 浏览 2 关注 1 回答 0 评论

问 What competencies are required for the person developing the Health-Based Exposure Limits (HBEL)?: 858 浏览 1 关注 1 回答 0 评论

问 How is a design space initiallydeveloped and verified at commercial scale?: 990 浏览 1 关注 1 回答 0 评论

技术支持 WeCenter © 2024 粤ICP备2023143277号-1